Comparison of commercial serum-free media for CHO-K1 cell growth and monoclonal antibody production

International Journal of Pharmaceutics

Volumn 437, Issue 1-2, 2012, Pages 303-305

  Rodrigues, Maria Elisa ^a   Costa, Ana Rita ^a   Henriques, Mariana ^a   Azeredo, Joana ^a   Oliveira, Rosário ^a  

^a UNIVERSITY OF MINHO   (Portugal)

Author keywords

Cell growth; CHO cells; Monoclonal antibody; Production; Serum free media

Indexed keywords

MONOCLONAL ANTIBODY;

ANTIBODY PRODUCTION; ARTICLE; CELL CULTURE; CELL GROWTH; CELL LINE; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION (PARAMETERS); CULTURE MEDIUM; GENETIC TRANSFECTION; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL PROLIFERATION; CHO CELLS; CRICETINAE; CRICETULUS; CULTURE MEDIA, SERUM-FREE;

EID: 84866732371     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.08.002     Document Type: Article

References (23)

1. A. Burgener, and M. Butler Medium development S. Ozturk, W.-S. Hu, Cell Culture Technology for Pharmaceutical and Cell-based Therapies 2006 CRC Press Boca Raton, FL 41 80
2. Z. Chen, K. Iding, D. Lütkemeyer, and J. Lehmann A low-cost chemically defined protein free medium for a recombinant CHO cell line producing prothrombin Biotechnol. Lett. 22 2000 837 841
3. J. Codamo, T. Munro, B. Hughes, M. Song, and P. Gray Enhanced CHO cell-based transient gene expression with the Epi-CHO expression system Mol. Biotechnol. 48 2011 109 115
4. A.R. Costa, M.E. Rodrigues, M. Henriques, D. Melton, P. Cunnah, R. Oliveira, and J. Azeredo Evaluation of the OSCAR™ system for the production of monoclonal antibodies by CHO-K1 cells Int. J. Pharm. 430 2012 42 46
5. P. Dhulipala, M. Liu, S. Beatty, M. Sabourin, G. Piras, S. Barrett, R. Hassett, and S. Gorfien Different cell culture media for single-cell cloning: requirements of CHO-S and CHO DG44 cells BioProcess Tech. 9 2011 44 51
6. M. Glassy, R. Peters, and A. Mikhalev Growth of human-human hybridomas in serum-free media enhances antibody secretion In Vitro Cell. Dev. Biol. Plant 23 1987 745 749
7. L. Grillberger, T.R. Kreil, S. Nasr, and M. Reiter Emerging trends in plasma-free manufacturing of recombinant protein therapeutics expressed in mammalian cells Biotechnol. J. 4 2009 186 201
8. G.F. Heidkamp, K. Neubert, E. Haertel, F. Nimmerjahn, M.C. Nussenzweig, and D. Dudziaka Efficient generation of a monoclonal antibody against the human C-type lectin receptor DCIR by targeting murine dendritic cells Immunol. Lett. 132 2010 69 78
9. N. Hemdan The role of interleukin-12 in the heavy metal-elicited immunomodulation: relevance of various evaluation methods J. Occup. Med. Toxicol. 3 2008 25
10. Y.-M. Huang, W. Hu, E. Rustandi, K. Chang, H. Yusuf-Makagiansar, and T. Ryll Maximizing productivity of CHO cell-based fed-batch culture using chemically defined media conditions and typical manufacturing equipment Biotechnol. Progr. 26 2010 1400 1410
11. Jayapal, K., Wlaschin, K., Hu, W.-S., Yap, M., 2007. Recombinant protein therapeutics from CHO cells - 20 years and counting. CHO Consortium: SBE Special Edition, 40-47.
12. M. Jeon, J.-B. Lim, and G. Lee Development of a serum-free medium for in vitro expansion of human cytotoxic T lymphocytes using a statistical design BMC Biotechnol. 10 2010 70
13. G.M. Lee, E.J. Kim, N.S. Kim, S.K. Yoon, Y.H. Ahn, and J.Y. Song Development of a serum-free medium for the production of erythropoietin by suspension culture of recombinant Chinese hamster ovary cells using a statistical design J. Biotechnol. 69 1999 85 93
14. C.-H. Liu, and T.-Y. Chang Rational development of serum-free medium for Chinese hamster ovary cells Process Biochem. 41 2006 2314 2319
15. S.S. Ozturk, and W.-S. Hu Cell Culture Technology for Pharmaceutical and Cell-Based Therapies 2006 CRC Press New York
16. P. Pazos, M. Boveri, A. Gennari, J. Casado, F. Fernandez, and P. Prieto Culturing cells without serum: lessons learnt using molecules of plant origin ALTEX 21 2004 67 72
17. M. Schröder, K. Matischak, and P. Friedl Serum- and protein-free media formulations for the Chinese hamster ovary cell line DUKXB11 J. Biotechnol. 108 2004 279 292
18. T.S. Stoll, K. Mühlethaler, U. von Stockar, and I.W. Marison Systematic improvement of a chemically-defined protein-free medium for hybridoma growth and monoclonal antibody production J. Biotechnol. 45 1996 111 123
19. Y.H. Sung, S.W. Lim, J.Y. Chung, and G.M. Lee Yeast hydrolysate as a low-cost additive to serum-free medium for the production of human thrombopoietin in suspension cultures of Chinese hamster ovary cells Appl. Microbiol. Biotechnol. 63 2004 527 536
20. G. Walsh Biopharmaceutical benchmarks 2010 Nat. Biotech. 28 2010 917 924
21. P. Wiedemann, M. Worf, H. Wiegemann, F. Egner, C. Schwiebert, J. Wilkesman, J. Guez, J. Quintana, D. Assanza, and H. Suhr On-line and real time cell counting and viability determination for animal cell process monitoring by in situ microscopy BMC Proc. 5 2011 77
22. S. Wilkening, F. Stahl, and A. Bader Comparison of primary human hepatocytes and hepatoma cell line hepg2 with regard to their biotransformation properties Drug Metab. Dispos. 31 2003 1035 1042
23. J. Zhu Mammalian cell protein expression for biopharmaceutical production Biotechnol. Adv. 30 2011 1158 1170